Deep Medicine Acquisition Corp. Rights (DMAQR) Key Ratios

$0.26

$-0.03 (-10.31%)

As on 31-Jan-2024 17:30EDT

Market cap

$-- Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Key Ratios and Highlights

Growth Score (%)	Quarterly		Annual (TTM)
Particulars	QoQ	YoY	1-Year	3-Years	5-Years
Revenue	--	--	--	--	--
EBIT	--	--	-49.31	--	--
Net Profit	-33.15	-162.35	92.47	--	--
EPS	-34.17	-320.23	-1,297.81	--	--
Book Value	--	--	-92.22	--	--

Key Ratios (%)	Average		Annual (TTM)
Particulars	3-Years	5-Years	TTM	Mar-23	Mar-22
EBIT-Margin	--	--	-3,129.50	--	--
Net Margin	--	--	-1,721.63	--	--
Return on equity	--	--	--	-0.63	-0.58
Return on Capital	--	--	--	-0.62	-0.57
Return on Assets	--	--	-9.17	-0.58	-0.55
Debt to Equity (x)	--	--	0.00	0.73	0.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	--	-0.62	-0.57	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROE

--

--

Profit after tax / Average Net worth * 100

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	--	-0.63	-0.58	--
Peer Median	30.40	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROA

--

--

Profit after tax / Average Total assets * 100

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	-9.17	-0.58	-0.55	--
Peer Median	-2.59	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	-3,129.50	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	-1,721.63	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	-49.31	25.77	--	--
Peer Median	57.78	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Profit Growth

--

--

Year on year growth in profit after tax

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	92.47	-11.74	--	--
Peer Median	-28.55	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EPS Growth

--

--

Year on year growth in earnings per share

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	-1,297.81	-3.22	--	--
Peer Median	5.65	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Book Value Growth

--

--

Year on year growth in book value per share

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	-237.69	--	--	--
Peer Median	-14.00	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	--	0.73	0.00	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	--	0.73	0.00	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Current Ratio

--

--

Current Assets / Current Liabilities and Provisions

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	1.86	3.50	240.27	--
Peer Median	0.15	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	1.86	--	--	--
Peer Median	0.14	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	-7.15	--	-55.85	--
Peer Median	1.52	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	--	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Asset Turnover

--

--

Sales / Average Total Assets

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	0.01	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	--	-0.84	-4.39	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	--	0.13	0.01	--
Peer Median	3.39	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	--	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EV/EBITDA

--

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name	TTM	Mar-23	Mar-22	Mar-21	Mar-20
Deep Medicine Acquisition Corp. Rights (DMAQR)	--	--	1.89	311.91	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly